These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6661187)

  • 1. Identification of fibronectin fragments that bind to carboxy-group-modified proteins.
    Vuento M; Sekiguchi K; Korkolainen M
    Biochem J; 1983 Dec; 215(3):613-6. PubMed ID: 6661187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of an actin-binding fragment of fibronectin.
    Keski-Oja J; Yamada KM
    Biochem J; 1981 Feb; 193(2):615-20. PubMed ID: 7030313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of fibronectin and its proteolytic fragments to glycosaminoglycans. Exposure of cryptic glycosaminoglycan-binding domains upon limited proteolysis.
    Sekiguchi K; Hakomori S; Funahashi M; Matsumoto I; Seno N
    J Biol Chem; 1983 Dec; 258(23):14359-65. PubMed ID: 6643486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin.
    Calaycay J; Pande H; Lee T; Borsi L; Siri A; Shively JE; Zardi L
    J Biol Chem; 1985 Oct; 260(22):12136-41. PubMed ID: 3900070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment.
    Clark RA; Wikner NE; Doherty DE; Norris DA
    J Biol Chem; 1988 Aug; 263(24):12115-23. PubMed ID: 3403561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deglycosylation of the chymotryptic collagen-binding fragment of human plasma fibronectin does not modify its affinity to denatured collagen.
    Delannoy P; Montreuil J
    FEBS Lett; 1989 Apr; 247(1):25-7. PubMed ID: 2707448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of phosphorylation sites on fibronectin.
    Ali IU
    FEBS Lett; 1984 Oct; 176(1):169-75. PubMed ID: 6386519
    [No Abstract]   [Full Text] [Related]  

  • 9. Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin.
    Zhu BC; Fisher SF; Pande H; Calaycay J; Shively JE; Laine RA
    J Biol Chem; 1984 Mar; 259(6):3962-70. PubMed ID: 6423638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-binding domains of human plasma fibronectin. pH and calcium ion modulation of fibronectin binding to DNA and heparin.
    Siri A; Balza E; Carnemolla B; Castellani P; Borsi L; Zardi L
    Eur J Biochem; 1986 Feb; 154(3):533-8. PubMed ID: 3948864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immobilization of soluble fibrin on factor XIIIa-coated polystyrene beads mediated by N-terminal fibronectin fragments. II. Demonstration of covalent adducts of fibrin peptide chains and fibronectin fragments.
    Hörmann H; Richter H; Jelinić V
    Biol Chem Hoppe Seyler; 1991 Jun; 372(6):427-30. PubMed ID: 1680341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain.
    Pande H; Calaycay J; Lee TD; Legesse K; Shively JE; Siri A; Borsi L; Zardi L
    Eur J Biochem; 1987 Jan; 162(2):403-11. PubMed ID: 3803394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma fibronectin possesses second binding site(s) to Staphylococcus aureus on its C-terminal region.
    Sakata N; Jakab E; Wadström T
    J Biochem; 1994 May; 115(5):843-8. PubMed ID: 7961595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneity.
    Garcia-Pardo A; Rostagno A; Frangione B
    Biochem J; 1987 Feb; 241(3):923-8. PubMed ID: 3593230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alignment of biologically active domains in the fibronectin molecule.
    Ruoslahti E; Hayman EG; Engvall E; Cothran WC; Butler WT
    J Biol Chem; 1981 Jul; 256(14):7277-81. PubMed ID: 6788765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of plasma fibronectin with special consideration of binding interferences.
    Köttgen E; Hoeft S; Müller C; Hell B
    J Clin Chem Clin Biochem; 1986 Aug; 24(8):541-9. PubMed ID: 3760786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional changes in the conformation of thrombospondin-1 during complexation with fibronectin or heparin.
    Dardik R; Lahav J
    Exp Cell Res; 1999 May; 248(2):407-14. PubMed ID: 10222132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The domains of human fibronectin mediating the binding of alpha antigen, the most immunopotent antigen of mycobacteria that induces protective immunity against mycobacterial infection.
    Naito M; Fukuda T; Sekiguchi K; Yamada T
    Biochem J; 2000 May; 347 Pt 3(Pt 3):725-31. PubMed ID: 10769176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the fibronectin COOH-terminal Fib-2 regions with fibrin: further characterization and localization of the Fib-2-binding sites.
    Makogonenko E; Ingham KC; Medved L
    Biochemistry; 2007 May; 46(18):5418-26. PubMed ID: 17425334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divalent cation modulation of fibronectin binding to heparin and to DNA.
    Hayashi M; Yamada KM
    J Biol Chem; 1982 May; 257(9):5263-7. PubMed ID: 6802851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.